Grand Medical

Grand Medical Pty Ltd, the innovative drug research and development center established by Grand Pharmaceutical in Australia, is currently developing STC3141, a globally innovative drug for the treatment of sepsis. Recently, it has been approved to conduct Phase Ib clinical trials for the treatment of sepsis in Belgium.